Freestone Capital Holdings’s CureVac CVAC Stock Holding History

Freestone Capital Holdings’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-140,073	Closed	-$755K	–	568
2025 Q3	$755K	Sell	140,073 -4,000	-3%	-$21.6K	0.02%	277
2025 Q2	$782K	Hold	144,073	–	–	0.03%	245
2025 Q1	$399K	Hold	144,073	–	–	0.01%	312
2024 Q4	$491K	Hold	144,073	–	–	0.02%	291
2024 Q3	$424K	Buy	144,073 +4,500	+3%	+$14.8K	0.01%	317
2024 Q2	$475K	Buy	+139,573	New	+$456K	0.02%	306
2021 Q1	–	Sell	-300	Closed	-$24.3K	–	546
2020 Q4	$24.3K	Buy	+300	New	+$23K	﹤0.01%	703

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Freestone Capital Holdings's CVAC Position: Q4 2025 in Review

Freestone Capital Holdings sold out of CureVac (CVAC) in Q4 2025, closing a stake of 140,073 shares — an estimated $755K sold.

Freestone Capital Holdings first reported a position in CVAC in Q4 2020 and held it in 7 quarters. The position peaked at $782K in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Freestone Capital Holdings reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Freestone Capital Holdings sold 140,073 CureVac shares in Q4 2025, an estimated $755K.
Freestone Capital Holdings first reported a position in CureVac in Q4 2020 and held it in 7 quarters.
Freestone Capital Holdings's CureVac position peaked at $782K in Q2 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Freestone Capital Holdings's 13F filing for Q4 2025, filed 23 Jan 2026.